Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium

Use of Platelet Rich Plasma (PRP) for Improving Thin Endometrium For IVF Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03166345

Acronym

PRPITM

Enrollment

150

Registered

2017-05-25

Start date

2017-08-15

Completion date

2018-04-01

Last updated

2018-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor Endometrium

Brief summary

Platelets rich plasma is simple source of growth factors and cytokines that can regulate endometrial growth for subgroup of thin endometrium women. It is an autologous source of this enhancing factors; therefore, there os no risk of using it within the same participant.

Interventions

OTHERTreatment of Thin Endometrium

This is a trial to improve endometrial thickness by autologous injection of PRP into the Uterine Cavity compared with CSF or no treatment.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* women with thin endometrium

Exclusion criteria

* serum positive hepatitis B and C women

Design outcomes

Primary

Measure	Time frame	Description
Mean Diameter of endometrial thickness	2 days	How the endometrium would respond after 2 days of PRP

Secondary

Measure	Time frame	Description
Clinical pregnancy rate	4 weeks or beyond after embryo Transfer	Registered fetal heartbeat 4 weeks or beyond after embryo transfer.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026